| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |